-+ 0.00%
-+ 0.00%
-+ 0.00%

CLEARMIND MEDICINE ANNOUNCES JOHNS HOPKINS IRB APPROVAL TO ADVANCE CMND-100 PHASE I/II CLINICAL TRIAL TO THE NEXT PARTS

Reuters·05/26/2026 12:25:00

Please log in to view news